KR20110138246A - 광학 영상화제 - Google Patents

광학 영상화제 Download PDF

Info

Publication number
KR20110138246A
KR20110138246A KR1020117024519A KR20117024519A KR20110138246A KR 20110138246 A KR20110138246 A KR 20110138246A KR 1020117024519 A KR1020117024519 A KR 1020117024519A KR 20117024519 A KR20117024519 A KR 20117024519A KR 20110138246 A KR20110138246 A KR 20110138246A
Authority
KR
South Korea
Prior art keywords
tissue
opt
group
polymer
optical imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020117024519A
Other languages
English (en)
Korean (ko)
Inventor
랜달 리 카터
제이슨 윌리암 캐슬
케네스 마이클 피쉬
애넙 수드
나탈리 앤 스테이플스
브라이언 더-란 리
Original Assignee
제너럴 일렉트릭 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제너럴 일렉트릭 캄파니 filed Critical 제너럴 일렉트릭 캄파니
Publication of KR20110138246A publication Critical patent/KR20110138246A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
KR1020117024519A 2009-03-19 2010-03-19 광학 영상화제 Withdrawn KR20110138246A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16153509P 2009-03-19 2009-03-19
US61/161,535 2009-03-19

Publications (1)

Publication Number Publication Date
KR20110138246A true KR20110138246A (ko) 2011-12-26

Family

ID=42331047

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117024519A Withdrawn KR20110138246A (ko) 2009-03-19 2010-03-19 광학 영상화제

Country Status (11)

Country Link
US (1) US20120114563A1 (cg-RX-API-DMAC7.html)
EP (1) EP2413976A1 (cg-RX-API-DMAC7.html)
JP (1) JP2012520856A (cg-RX-API-DMAC7.html)
KR (1) KR20110138246A (cg-RX-API-DMAC7.html)
CN (1) CN102438659A (cg-RX-API-DMAC7.html)
AU (1) AU2010224789A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI1009346A2 (cg-RX-API-DMAC7.html)
CA (1) CA2755770A1 (cg-RX-API-DMAC7.html)
MX (1) MX2011009808A (cg-RX-API-DMAC7.html)
RU (1) RU2011138096A (cg-RX-API-DMAC7.html)
WO (1) WO2010106169A1 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201015806D0 (en) 2010-09-21 2010-10-27 Ge Healthcare As Vascular imaging agents
US10053447B2 (en) 2010-12-21 2018-08-21 Pierce Biotechnology, Inc Fluorescent compounds
US8889884B1 (en) 2011-07-14 2014-11-18 Pierce Biotechnology, Inc. Phosphine derivatives of fluorescent compounds
CN103874512B (zh) 2011-07-29 2016-11-16 艾维拉斯生物科学公司 选择性递送分子及使用方法
US9249307B2 (en) 2011-08-16 2016-02-02 Pierce Biotechnology, Inc. Benzocyanine compounds
GB201116733D0 (en) 2011-09-28 2011-11-09 Ge Healthcare As Peptide margin imaging agents
US9751868B2 (en) 2012-02-28 2017-09-05 Pierce Biotechnology, Inc. Benzocyanine compounds
CN104395306B (zh) 2012-03-02 2019-04-23 皮尔斯生物科技有限公司 作为生物分子的标记染料的吲哚衍生物
JP6288970B2 (ja) * 2012-07-20 2018-03-07 キヤノン株式会社 化合物、および、前記化合物を有する光音響イメージング用造影剤
CN104470546B (zh) * 2012-07-20 2018-02-27 佳能株式会社 化合物和含有所述化合物的光声成像造影剂
US9676787B2 (en) 2012-08-28 2017-06-13 Pierce Biotechnology, Inc. Benzopyrylium compounds
WO2014055253A1 (en) * 2012-10-04 2014-04-10 The General Hospital Corporation Methods of synthesizing and using peg-like fluorochromes
JP6325461B2 (ja) * 2013-01-28 2018-05-16 国立研究開発法人科学技術振興機構 組織透明化方法、組織透明化試薬及び組織観察方法
CN105102484B (zh) * 2013-01-30 2020-03-10 艾维拉斯生物科学公司 选择性递送分子及使用方法
FR3001463B1 (fr) * 2013-01-31 2015-02-20 Commissariat Energie Atomique Particules luminescentes de carbone, procede de preparation et utilisation
EP3052136A4 (en) * 2013-10-02 2017-06-21 University of Massachusetts Surface functionalized, host-guest polymer nano-assemblies and methods thereof
US9416276B2 (en) 2013-11-07 2016-08-16 Canon Kabushiki Kaisha Method for producing contrast agent
US10245329B2 (en) 2014-09-08 2019-04-02 Canon Kabushiki Kaisha Composition having dye and conjugate of polyethyleneglycol and additive and contrast agent for photoacoustic imaging having the same
WO2016060277A1 (en) 2014-10-16 2016-04-21 Canon Kabushiki Kaisha Polymer, and contrast agent for photoacoustic imaging, including the polymer
JP6736278B2 (ja) 2014-10-24 2020-08-05 キヤノン株式会社 重合体、前記重合体を有する光音響イメージング用造影剤
JP6700750B2 (ja) 2014-12-09 2020-05-27 キヤノン株式会社 化合物、および、前記化合物を有する光学イメージング用造影剤
JP6793122B2 (ja) * 2014-12-19 2020-12-02 ブラッコ・イメージング・ソシエタ・ペル・アチオニBracco Imaging S.P.A. 術中イメージング
US10383957B2 (en) 2015-01-06 2019-08-20 Anthony H. de Haas Near-infrared fluorescent surgical dye markers
JP2017002000A (ja) 2015-06-12 2017-01-05 キヤノン株式会社 化合物又はその薬学的に受容可能な塩、及び、前記化合物又はその薬学的に受容可能な塩を有する光音響イメージング用造影剤。
JP6789636B2 (ja) 2015-09-30 2020-11-25 キヤノン株式会社 重合体、前記重合体を有する光音響イメージング用造影剤
WO2017057653A1 (en) 2015-09-30 2017-04-06 Canon Kabushiki Kaisha Conjugate of polysarcosine and nir contrast agent for photoacoustic imaging
CN105688230B (zh) * 2016-02-02 2018-12-11 史春梦 七甲川吲哚花菁染料-聚乙二醇-叶酸复合物及制备方法和应用
CN109054013A (zh) * 2018-08-22 2018-12-21 东北大学 一种经修饰的吲哚菁绿及其制备方法
CN109738387A (zh) * 2018-12-29 2019-05-10 佛山科学技术学院 一种基于吲哚箐绿的光学相干层析成像方法和装置
WO2025197935A1 (ja) * 2024-03-19 2025-09-25 国立大学法人 東京大学 薬物-ポリマー複合体、医薬組成物、および薬物送達用ポリマー

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622685A (en) 1990-05-30 1997-04-22 Deutches Krebsforchunszentrum Stiftung Des Offentlichen Rechts Polyether-substituted porphyrin anti-tumor agents
DE4445065A1 (de) 1994-12-07 1996-06-13 Diagnostikforschung Inst Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung
DE69820867T2 (de) 1997-04-29 2004-11-18 Amersham Health As Lichtbilderzeugungskontrastmitteln
GB2337523A (en) * 1998-04-29 1999-11-24 Nycomed Imaging As Light imaging contrast agents
US20100143258A1 (en) * 2008-12-05 2010-06-10 General Electric Company Tumor margin imaging agents

Also Published As

Publication number Publication date
US20120114563A1 (en) 2012-05-10
CN102438659A (zh) 2012-05-02
RU2011138096A (ru) 2013-04-27
MX2011009808A (es) 2011-09-30
AU2010224789A1 (en) 2011-10-06
CA2755770A1 (en) 2010-09-23
EP2413976A1 (en) 2012-02-08
WO2010106169A1 (en) 2010-09-23
BRPI1009346A2 (pt) 2017-05-30
JP2012520856A (ja) 2012-09-10

Similar Documents

Publication Publication Date Title
US20120114563A1 (en) Optical imaging agents
Yang et al. Semiconducting polymer nanoparticles as theranostic system for near-infrared-II fluorescence imaging and photothermal therapy under safe laser fluence
RU2475266C2 (ru) Оптические агенты визуализации
EP2393420B1 (en) Charge-balanced imaging agents
US20100303727A1 (en) Optical imaging agents
JP2017503004A (ja) 近赤外蛍光造影バイオイメージング剤及びその使用方法
JP2010534711A (ja) ペプチドイメージング剤
US20090137902A1 (en) Intraoperative imaging methods
US20110268660A1 (en) Method for detecting dysplasia
US10493169B2 (en) Use of charge-balanced imaging agents for determining renal function
WO2025059124A1 (en) N-oxide based zwitterionic near infrared fluorophore imaging agents and methods of use therefor
JP2025535225A (ja) 近赤外リンパ造影用組成物及びその用法・用量
US10172964B2 (en) Compound or salt thereof and contrast agent for optical imaging
US20130331690A1 (en) Vascular imaging agents
WO2024145492A9 (en) cRGD -CONJUGATED IMAGING AGENT
WO2017057653A1 (en) Conjugate of polysarcosine and nir contrast agent for photoacoustic imaging
WO2013045662A1 (en) Peptide margin imaging agents
WO2025059044A1 (en) Targeting ligands for disease-targeted imaging agents and methods of use therefor
St Lorenz Advancing Nanotechnology for Photoacoustic Imaging
WO2022202863A1 (ja) がん造影用組成物
WO2013045650A2 (en) Infusion imaging method
HK1148476A (en) Labelled hgf binding peptides for imaging

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20111018

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid